Vivo Capital, LLC
Top Portfolio Positions
44 positions ·
$1,164,469,705 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| ERAS |
Erasca, Inc.
|
12,151,480 | $196,610,946 | 16.88% |
| PRAX |
Praxis Precision Medicines, Inc.
|
338,895 | $109,188,580 | 9.38% |
| TERN |
Terns Pharmaceuticals, Inc.
|
1,334,418 | $70,350,516 | 6.04% |
| TRVI |
Trevi Therapeutics, Inc.
|
5,094,668 | $60,779,389 | 5.22% |
| DBVT |
DBV Technologies S.A.
|
2,667,569 | $55,725,516 | 4.79% |
| CMPX |
Compass Therapeutics, Inc.
|
9,545,466 | $50,495,515 | 4.34% |
| TNGX |
Tango Therapeutics, Inc.
|
2,154,780 | $45,077,997 | 3.87% |
| SABS |
SAB Biotherapeutics, Inc.
|
11,420,000 | $43,738,600 | 3.76% |
| CRVS |
Corvus Pharmaceuticals, Inc.
|
2,805,816 | $41,049,088 | 3.53% |
| DRUG |
Bright Minds Biosciences Inc.
|
557,172 | $40,656,840 | 3.49% |
Holdings in DTIL
Export CSV
1 of 1 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,712 | 4,675 | Shares | Sole | 2026-05-20 | |
| No quarters match your search. | ||||||